A cluster of new studies has identified several previously overlooked biological routes through which Alzheimer’s disease ...

The remodelling of the human brain's immune environment by the tuberculosis vaccine BCG could offer a potential biological ...

A new study suggests that the tuberculosis vaccine BCG could reduce Alzheimer's disease risk by reshaping the brain's immune ...

The Garmin Forerunner 970 is stacked with training insights, but it takes some extra research to make the most of such a ...

Scientists at MD Anderson Cancer Center have revealed how ATRX mutations restructure chromatin and activate oncogenic ...

Sure, here is the description with all links and additional text removed: If you found this video enjoyable, kindly show your ...

HOUSTON, JULY 1, 2026 ― A new study from researchers at The University of Texas MD Anderson Cancer Center has uncovered how one of the most common ...

Biomedical engineers use iPSCs to grow specialized retinal endothelial cells, successfully regenerating damaged eye blood ...

Researchers have identified a vitamin B12–based compound that can cross the blood-brain barrier and home in on glioblastoma tumors. In animal studies, the compound accumulated preferentially in tumor ...

For the first time ever, scientists are attempting to reverse cellular aging in a living patient. The target: incurable vision loss. The risk: cancer.

A newly discovered molecule, OLE, restored the brain’s immune cells to a more protective state in Alzheimer’s disease models. The treatment reduced the accumulation of toxic plaques and improved ...

A groundbreaking human trial of ER-100, a cellular reprogramming therapy, has begun, testing whether damaged eye cells can be rejuvenated and potentially opening a new chapter in the science of aging.